NYSE:ABCAmerisourceBergen Stock Price, Forecast & News

$99.45

-0.04 (-0.04 %)

(As of 06/4/2020 04:00 PM ET)

Add

Compare

Today's Range

$98.20

Now: $99.45▼

$99.99

50-Day Range

$84.03

MA: $89.50▼

$98.66

52-Week Range

$72.06

Now: $99.45▼

$99.99

Volume1.47 million shs

Average Volume1.70 million shs

Market Capitalization$20.23 billion

P/E Ratio13.09

Dividend Yield1.69%

Beta0.62

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers. It also provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; and packaging solutions to various institutional and retail healthcare providers. In addition, this segment distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; provides other services primarily to physicians who specialize in various disease states, primarily oncology, as well as to other healthcare providers, including hospitals and dialysis clinics; and offers data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers. The company's Other segment provides integrated manufacturer services, such as clinical trial support, product post-approval, and commercialization support; offers specialty transportation and logistics services for the biopharmaceutical industry; and sells pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and various other products to customers in both the companion animal and production animal markets, as well as provides demand-creating sales force services to manufacturers. AmerisourceBergen Corporation was founded in 1985 and is headquartered in Chesterbrook, Pennsylvania.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
AmerisourceBergen has received a consensus rating of Buy. The company's average rating score is 2.63, and is based on 5 buy ratings, 3 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $103.00, AmerisourceBergen has a potential upside of 3.6% from its current price of $99.45.
Amount of Analyst Coverage
AmerisourceBergen has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.5 Community Rank

Outperform Votes
AmerisourceBergen has received 669 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AmerisourceBergen has received 678 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AmerisourceBergen has received 50.33% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AmerisourceBergen and other stocks. Vote “Outperform” if you believe ABC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ABC will underperform the S&P 500 over the long term. You may vote once every thirty days.

5.0 Dividend Strength

Dividend Leadership
AmerisourceBergen is a leading dividend payer. It pays a dividend yield of 1.69%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
AmerisourceBergen has been increasing its dividend for 15 years.
Dividend Coverage
The dividend payout ratio of AmerisourceBergen is 23.70 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, AmerisourceBergen will have a dividend payout ratio of 20.69 % next year. This indicates that AmerisourceBergen will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AmerisourceBergen insiders have sold 3,554.60% more of their company's stock than they have bought. Specifically, they have bought $100,346.00 in company stock and sold $3,667,243.00 in company stock.
Percentage Held by Insiders
Only 28.30% of the stock of AmerisourceBergen is held by insiders.
Percentage Held by Institutions
64.25% of the stock of AmerisourceBergen is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for AmerisourceBergen are expected to grow by 8.99% in the coming year, from $7.45 to $8.12 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of AmerisourceBergen is 13.09, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 16.28.
Price to Earnings Ratio vs. Sector
The P/E ratio of AmerisourceBergen is 13.09, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.54.
Price to Earnings Growth Ratio
AmerisourceBergen has a PEG Ratio of 1.86. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
AmerisourceBergen has a P/B Ratio of 6.87. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.54 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Drugs, proprietaries, & sundries

Sub-IndustryHealth Care Distributors

SectorMedical

Current SymbolNYSE:ABC

Previous Symbol

CUSIP03073E10

CIK1140859

Webwww.amerisourcebergen.com

Phone610-727-7000

Debt

Debt-to-Equity Ratio0.98

Current Ratio0.97

Quick Ratio0.63

Price-To-Earnings

Trailing P/E Ratio13.09

Forward P/E Ratio13.35

P/E Growth1.86

Sales & Book Value

Annual Sales$179.59 billion

Price / Sales0.11

Cash Flow$9.75 per share

Price / Cash Flow10.20

Book Value$14.48 per share

Price / Book6.87

Profitability

EPS (Most Recent Fiscal Year)$7.09

Net Income$855.36 million

Net Margins0.85%

Return on Equity48.85%

Return on Assets3.94%

Miscellaneous

Employees22,000

Outstanding Shares203,402,000

Market Cap$20.23 billion

Next Earnings Date8/6/2020 (Estimated)

OptionableOptionable

Receive ABC News and Ratings via Email

Sign-up to receive the latest news and ratings for ABC and its competitors with MarketBeat's FREE daily newsletter.

AmerisourceBergen (NYSE:ABC) Frequently Asked Questions

How has AmerisourceBergen's stock been impacted by COVID-19 (Coronavirus)?

AmerisourceBergen's stock was trading at $84.96 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, ABC stock has increased by 17.1% and is now trading at $99.45. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of AmerisourceBergen?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AmerisourceBergen in the last year. There are currently 3 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for AmerisourceBergen.

When is AmerisourceBergen's next earnings date?

AmerisourceBergen is scheduled to release its next quarterly earnings announcement on Thursday, August 6th 2020. View our earnings forecast for AmerisourceBergen.

How were AmerisourceBergen's earnings last quarter?

AmerisourceBergen Corp. (NYSE:ABC) posted its quarterly earnings data on Thursday, May, 7th. The company reported $2.40 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $2.27 by $0.13. The company had revenue of $47.42 billion for the quarter, compared to the consensus estimate of $45.90 billion. AmerisourceBergen had a return on equity of 48.85% and a net margin of 0.85%. The firm's revenue for the quarter was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $2.11 EPS. View AmerisourceBergen's earnings history.

How often does AmerisourceBergen pay dividends? What is the dividend yield for AmerisourceBergen?

AmerisourceBergen declared a quarterly dividend on Thursday, January 30th. Investors of record on Friday, February 14th will be given a dividend of $0.42 per share on Monday, March 2nd. This represents a $1.68 dividend on an annualized basis and a dividend yield of 1.69%. The ex-dividend date is Thursday, February 13th. This is a positive change from AmerisourceBergen's previous quarterly dividend of $0.40. View AmerisourceBergen's dividend history.

What guidance has AmerisourceBergen issued on next quarter's earnings?

AmerisourceBergen updated its FY20 earnings guidance on Thursday, May, 7th. The company provided earnings per share guidance of $7.35-7.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.57.

What price target have analysts set for ABC?

8 brokers have issued 12-month price targets for AmerisourceBergen's stock. Their forecasts range from $94.00 to $112.00. On average, they anticipate AmerisourceBergen's share price to reach $103.00 in the next twelve months. This suggests a possible upside of 3.6% from the stock's current price. View analysts' price targets for AmerisourceBergen.

Has AmerisourceBergen been receiving favorable news coverage?

Media coverage about ABC stock has been trending somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. AmerisourceBergen earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an impact on the company's share price in the immediate future. View the latest news aboutAmerisourceBergen.

Are investors shorting AmerisourceBergen?

AmerisourceBergen saw a decline in short interest in May. As of May 15th, there was short interest totaling 3,830,000 shares, a decline of 10.1% from the April 30th total of 4,260,000 shares. Based on an average daily trading volume, of 1,940,000 shares, the short-interest ratio is presently 2.0 days. Currently, 2.6% of the shares of the stock are sold short. View AmerisourceBergen's Current Options Chain.

Who are some of AmerisourceBergen's key competitors?

Some companies that are related to AmerisourceBergen include McKesson (MCK), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI). View all competitors.

What other stocks do shareholders of AmerisourceBergen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AmerisourceBergen investors own include Intel (INTC), Walt Disney (DIS), AbbVie (ABBV), CVS Health (CVS), Cisco Systems (CSCO), NVIDIA (NVDA), Netflix (NFLX), Pfizer (PFE), JPMorgan Chase & Co. (JPM) and Gilead Sciences (GILD).

Who are AmerisourceBergen's key executives?

AmerisourceBergen's management team includes the following people:

Mr. Steven H. Collis, Chairman, Pres & CEO (Age 58)
Mr. James F. Cleary Jr., CFO & Exec. VP (Age 56)
Mr. John G. Chou, Exec. VP and Chief Legal & Bus. Officer (Age 63)
Dr. Robert P. Mauch PharmD, Ph.D., Exec. VP & Group Pres (Age 52)
Mr. Dale B. Danilewitz, Exec. VP & Chief Information Officer (Age 57)

What is AmerisourceBergen's stock symbol?

AmerisourceBergen trades on the New York Stock Exchange (NYSE) under the ticker symbol "ABC."

Who are AmerisourceBergen's major shareholders?

AmerisourceBergen's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.53%), State Street Corp (3.46%), JPMorgan Chase & Co. (2.38%), Geode Capital Management LLC (1.19%), Bank of New York Mellon Corp (1.11%) and Victory Capital Management Inc. (0.98%). Company insiders that own AmerisourceBergen stock include Dale Danilewitz, Dermot Mark Durcan, Gina Clark, Henry Wadsworth Mcgee III, James F Cleary Jr, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Lazarus Krikorian, Richard W Gochnauer, Robert P Mauch, Steven H Collis and Tim G Guttman. View institutional ownership trends for AmerisourceBergen.

Which major investors are selling AmerisourceBergen stock?

ABC stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Victory Capital Management Inc., Victory Capital Management Inc., BlackRock Inc., Schroder Investment Management Group, APG Asset Management N.V., Morgan Stanley, and Morgan Stanley. Company insiders that have sold AmerisourceBergen company stock in the last year include Gina Clark, Henry Wadsworth Mcgee III, John G Chou, Kathleen W Hyle, Kathy H Gaddes, Richard W Gochnauer, Robert P Mauch, and Steven H Collis. View insider buying and selling activity for AmerisourceBergen.

Which major investors are buying AmerisourceBergen stock?

ABC stock was acquired by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., TimesSquare Capital Management LLC, AQR Capital Management LLC, Retirement Systems of Alabama, Rothschild & Co. Asset Management US Inc., Bank of New York Mellon Corp, State of Tennessee Treasury Department, and Swiss National Bank. Company insiders that have bought AmerisourceBergen stock in the last two years include Dermot Mark Durcan, and James F Cleary Jr. View insider buying and selling activity for AmerisourceBergen.

How do I buy shares of AmerisourceBergen?

Shares of ABC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is AmerisourceBergen's stock price today?

One share of ABC stock can currently be purchased for approximately $99.45.

How big of a company is AmerisourceBergen?

AmerisourceBergen has a market capitalization of $20.23 billion and generates $179.59 billion in revenue each year. The company earns $855.36 million in net income (profit) each year or $7.09 on an earnings per share basis. AmerisourceBergen employs 22,000 workers across the globe.

What is AmerisourceBergen's official website?

The official website for AmerisourceBergen is www.amerisourcebergen.com.

How can I contact AmerisourceBergen?

AmerisourceBergen's mailing address is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. The company can be reached via phone at 610-727-7000 or via email at [email protected]

This page was last updated on 6/4/2020 by MarketBeat.com Staff